5
Harmonized Definition
c
Metabolic Risk
(as defined in this guideline)
None 40–75 years
3 of the 5 below 3 of the 5 below
Population and country-specific
definitions determined by local
organizations
WC ≥102 cm in men or ≥88 cm in
women (non-Asian origin)
WC ≥90 cm in men or ≥80 cm in women
(both East Asians and South Asians)
TGL ≥150 mg/dL (≥1.7 mmol/L)
or on TGL Rx
TGL ≥150 mg/dL (≥1.7mmol/L)
or on TGL Rx
HDL-C <40 mg/dL (<1.0 mmol/L) in
men or <50 mg/dL (<1.3 mmol/L) in
women or on HDL-C Rx
HDL-C <40 mg/dL (<1.0 mmol/L) in
men or <50 mg/dL (<1.3 mmol/L) in
women or on HDL-C Rx
≥130 mmHg systolic or ≥85 diastolic or
on hypertension Rx
≥130 mmHg systolic or ≥80 diastolic or
on hypertension Rx
Fasting glucose >100 mg/dL (5.6 mmol/L)
or on drug treatment for elevated glucose
Fasting glucose ≥100 mg/dL (≥5.6
mmol/L) and <126 mg/dL (<7.0
mmol/L), OR 2 hr. OGTT ≥140 mg/dL
(≥7.8 mmol/L), and <200 mg/dL (<11.0
mmol/L), OR HbA1c ≥5.7%–6.4%
OR on drug treatment for elevated glucose
without diagnosis of DM
c
Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim
statement of the International Diabetes Federation Task Force on Epidemiolog y and Prevention;
National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;
International Atherosclerosis Society; and International Association for the Study of Obesity.
Circulation. 2009;120(16):1640-1645.
